CA2002182A1 - Compositions pour le traitement du syndrome premenstruel ou de la phase luteinique tardive, et leur mode d'emploi - Google Patents
Compositions pour le traitement du syndrome premenstruel ou de la phase luteinique tardive, et leur mode d'emploiInfo
- Publication number
- CA2002182A1 CA2002182A1 CA 2002182 CA2002182A CA2002182A1 CA 2002182 A1 CA2002182 A1 CA 2002182A1 CA 2002182 CA2002182 CA 2002182 CA 2002182 A CA2002182 A CA 2002182A CA 2002182 A1 CA2002182 A1 CA 2002182A1
- Authority
- CA
- Canada
- Prior art keywords
- methods
- compositions
- premenstrual
- treating
- luteal phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2002182 CA2002182C (fr) | 1989-11-03 | 1989-11-03 | Compositions pour le traitement du syndrome premenstruel ou de la phase luteinique tardive, et leur mode d'emploi |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2002182 CA2002182C (fr) | 1989-11-03 | 1989-11-03 | Compositions pour le traitement du syndrome premenstruel ou de la phase luteinique tardive, et leur mode d'emploi |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2002182A1 true CA2002182A1 (fr) | 1991-05-03 |
CA2002182C CA2002182C (fr) | 2000-06-13 |
Family
ID=4143458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2002182 Expired - Fee Related CA2002182C (fr) | 1989-11-03 | 1989-11-03 | Compositions pour le traitement du syndrome premenstruel ou de la phase luteinique tardive, et leur mode d'emploi |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2002182C (fr) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006108591A1 (fr) | 2005-04-11 | 2006-10-19 | Novartis Ag | 1h-quinaz0line-2,4-diones et leur utilisation en tant que ligands du recepteur ampa |
EP2336129A1 (fr) | 2004-06-18 | 2011-06-22 | Novartis AG | 1-aza-bicyclo[3.3.1]nonanes |
EP2354141A1 (fr) | 2005-12-16 | 2011-08-10 | Novartis AG | (1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1h-indol-5-yl)-heteroaryl]-amines en tant que ligands cholinergiques du n-achr pour le traitement de troubles psychotiques et neurodegeneatifs |
EP2361914A1 (fr) | 2005-12-16 | 2011-08-31 | Novartis AG | [(1h-indol-5-yl)-heteroaryloxy]-(1-aza-bicyclo[3.3.1]nonanes comme ligands cholinergiques de n-achr pour le traitement des troubles psychotiques et neurodegeneratifs. |
EP2457911A1 (fr) | 2004-07-14 | 2012-05-30 | Novartis AG | Dérivés de 3-(hétéroaryl-oxy)-2-alkyl-1-aza-bicycloalkyle en tant que ligands nAChR alpha7 pour le traitement des maladies du SNC |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0220581D0 (en) | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
-
1989
- 1989-11-03 CA CA 2002182 patent/CA2002182C/fr not_active Expired - Fee Related
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2336129A1 (fr) | 2004-06-18 | 2011-06-22 | Novartis AG | 1-aza-bicyclo[3.3.1]nonanes |
EP2457911A1 (fr) | 2004-07-14 | 2012-05-30 | Novartis AG | Dérivés de 3-(hétéroaryl-oxy)-2-alkyl-1-aza-bicycloalkyle en tant que ligands nAChR alpha7 pour le traitement des maladies du SNC |
WO2006108591A1 (fr) | 2005-04-11 | 2006-10-19 | Novartis Ag | 1h-quinaz0line-2,4-diones et leur utilisation en tant que ligands du recepteur ampa |
EP2463278A1 (fr) | 2005-04-11 | 2012-06-13 | Novartis AG | 1h-quinaz0line-2,4-diones et leur utilisation en tant que ligands du recepteur ampa |
EP2468732A1 (fr) | 2005-04-11 | 2012-06-27 | Novartis AG | 1H-quinazoline-2,4-diones |
EP2476671A1 (fr) | 2005-04-11 | 2012-07-18 | Novartis AG | 1H-quinazoline-2,4-diones |
EP2354141A1 (fr) | 2005-12-16 | 2011-08-10 | Novartis AG | (1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1h-indol-5-yl)-heteroaryl]-amines en tant que ligands cholinergiques du n-achr pour le traitement de troubles psychotiques et neurodegeneatifs |
EP2361914A1 (fr) | 2005-12-16 | 2011-08-31 | Novartis AG | [(1h-indol-5-yl)-heteroaryloxy]-(1-aza-bicyclo[3.3.1]nonanes comme ligands cholinergiques de n-achr pour le traitement des troubles psychotiques et neurodegeneratifs. |
Also Published As
Publication number | Publication date |
---|---|
CA2002182C (fr) | 2000-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2001572A1 (fr) | Composes pour le traitement des symptomes de sevrage du tabac | |
MY106272A (en) | Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants. | |
EP0419653A4 (en) | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof | |
DE69202207D1 (de) | Verfahren zur Herstellung von 1-Chlor-1,1,3,3,3-Pentafluorpropan und von 1,1,1,3,3,3-Hexafluorpropan. | |
IE893712L (en) | Quinuclidines, their use as medicaments and processes for¹their preparation | |
IL96458A0 (en) | Isoxazolines,their preparation,and their use as plantprotecting agents | |
AU5642294A (en) | Bacteriocidal gas composition and process for preparing the same | |
DE3856295D1 (de) | Behandlung des prämenstruellen oder späten lutealsphase-syndroms | |
RU93058535A (ru) | Таблетка, содержащая гидрохлорид колестипола и способ ее получения | |
AU7239794A (en) | Process for preparing 5,8-dihydronaphthoquinone derivatives, novel 5,8-dihydronaphthoquinone derivatives and their use as anticancer agent | |
LTIP1687A (en) | Novel antiarrhythmic agents, process for the preparation thereof and pharmaceutical compositions | |
CA2002182A1 (fr) | Compositions pour le traitement du syndrome premenstruel ou de la phase luteinique tardive, et leur mode d'emploi | |
GB8917687D0 (en) | Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same | |
PT66089B (en) | Process for preparing 1,2-benzisothiazolin-3-ona with anti-thrombotic effect application of same for the preparationof pharmaceutical compositions with anti-thrombic effect and application of these pharmaceutical compositions for the treatment of thrombosis | |
ZA925892B (en) | Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases. | |
EP0318233A3 (fr) | Inhibiteurs d'assimilation de sérotonine et de norépinéphrine | |
EP0264744A3 (en) | Process for the preparation of 4,4'-diaminodiphenylmethane and its derivatives. | |
LTIP911A (en) | Indenoindole compounds i,process for preparing thereof,pharmaceutical compositions containing this compounds,and their use | |
AU4926190A (en) | 2,3,23-trihydroxy-urs-12-ene and its derivatives, processes for their preparation and their use | |
CA2263846A1 (fr) | Nouveaux derives de pyranoside | |
ZA906744B (en) | Novel aminopropanol derivatives,process for their preparation and pharmaceutical compositions comprising the same | |
IL95210A0 (en) | 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same | |
CA2019745A1 (fr) | Preparation pour le traitement et la prevention des thromboses et des complications thromboemboliques, utilisation d'une telle preparation et methode de production | |
EP0386920A3 (fr) | Dérivés d'hydroxy-2-thiénylox-3-propylamine | |
HUT53773A (en) | Antidotums containing substituted 1,8-naphtiridine derivatives as aktive components and process for producing the active components |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |